Food and Drug Administration (FDA)

The U.S. Supreme Court on May 14 blocked an appeals court ruling that sought to pause a federal policy permitting mifepristone, sometimes called the abortion pill, to be dispensed through …

President Donald Trump on May 12 confirmed that Marty Makary, the embattled FDA commissioner criticized by pro-life advocates and others, will leave his post.

The state lawsuits seek to end the FDA policy implemented during the Biden administration permitting mifepristone to be distributed by mail.

Louisiana’s request to block the regulation permitting mifepristone to be sent by mail was denied, but it could renew its case after the review. 

WASHINGTON (OSV News) — A group of U.S. senators who oppose abortion sent investigatory letters to three abortion drug manufacturers seeking information about their products, as well as a similar letter …

The Safeguarding Women from Chemical Abortion Act, if enacted, would revoke the Food and Drug Administration’s approval of the drug.

DOJ lawyers in the Trump administration argued in the filing that the court “should either stay this case until after FDA completes its review or dismiss it.”

Lawyers for Louisiana asked a federal judge Feb. 24 to roll back relaxed restrictions on mifepristone, a drug commonly, but not exclusively, used for abortion.

A key national pro-life group released polling it said shows a potential failure to act on pro-life policy priorities may demotivate Republican primary voters in the upcoming midterm elections. 

A key pro-life group said the Justice Department is undermining Louisiana’s efforts to roll back the Biden administration’s restrictions on the abortion pill.